VYNE Therapeutics Inc. (VYNE) Social Stream



VYNE Therapeutics Inc. (VYNE): $2.20

0.05 (+2.33%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add VYNE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#196 of 356

in industry

VYNE THERAPEUTICS INC (VYNE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering VYNE.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-16 6 $14 $3 $6.666 $2.51 165.58%
2021-11-11 6 $14 $3 $7.2 $2.51 186.85%
2021-12-06 4 $14 $3 $7.166 $2.51 185.5%
2022-03-21 6 $14 $3 $7.166 $2.51 185.5%
2022-04-07 5 $14 $3 $7.166 $2.51 185.5%
2022-05-18 5 $10 $3 $5.8 $2.51 131.08%
2022-08-10 5 $10 $1.5 $4.875 $2.51 94.22%
2022-08-15 5 $5 $1.5 $3.625 $2.51 44.42%
2022-10-11 6 $5 $1.5 $3.7 $2.51 47.41%
2022-11-11 5 $89.928 $26.978 $69.694 $2.51 2676.65%
2023-03-10 5 $89.93 $26.978 $69.694 $2.51 2676.65%
2023-03-14 4 $89.93 $28 $58.965 $2.51 2249.2%
2023-05-12 3 $71.941 $9 $36.313 $2.51 1346.73%
2023-08-15 4 $71.941 $9 $36.313 $2.51 1346.73%
2023-09-26 4 $28 $5 $14 $2.51 457.77%
2023-10-31 3 $5.75 $5 $5.375 $2.51 114.14%
2023-11-13 3 $6 $5 $5.583 $2.51 122.43%

The Trend in the Analyst Price Target


Over the past 35 months, VYNE's average price target has gone down $0.11.

VYNE reports an average of 1,088.73% for its upside potential over the past 35 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-10 5 89.930 26.978 69.694 2.610 2570.27%
2023-03-14 5 89.930 28.000 69.950 2.410 2802.49%
2023-08-15 4 71.941 9.000 36.313 4.850 648.72%
2023-09-26 4 28.000 5.000 14.000 3.599 289%
2023-11-10 3 6.000 5.000 5.583 3.510 59.06%

VYNE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


VYNE's average broker recommendation rating improved by 0 over the prior 26 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, VYNE THERAPEUTICS INC's variance in analysts' estimates is lower than -1958.41% of them.
  • VYNE has a higher upside potential (average analyst target price relative to current price) than 2115.94% of all US stocks.
  • In the context of stocks in the small market cap category, VYNE THERAPEUTICS INC's average analyst price target is higher than 992.97% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, VYNE THERAPEUTICS INC's number of analysts covering the stock is higher than 546.37% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to VYNE THERAPEUTICS INC are CUE, ENSC, and NRXP.

Is VYNE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!